Monday, September 28, 2009

Vical Licensee Sanofi-aventis Completes Enrollment in Phase 3 Angiogenesis Trial: http://bit.ly/3w1nXl
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)